ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 244 filers reported holding ALKERMES PLC in Q1 2022. The put-call ratio across all filers is 0.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,522 | +16.7% | 268,543 | +30.4% | 0.35% | +26.4% |
| Q2 2023 | $6,444 | +16.8% | 205,869 | +5.2% | 0.28% | +7.7% |
| Q1 2023 | $5,517 | +19.4% | 195,699 | +10.6% | 0.26% | +1.6% |
| Q4 2022 | $4,622 | -99.9% | 176,900 | +4.5% | 0.26% | +12.3% |
| Q3 2022 | $3,781,000 | +27.8% | 169,314 | +70.5% | 0.23% | +2.7% |
| Q2 2022 | $2,958,000 | +102.2% | 99,306 | +78.6% | 0.22% | +131.2% |
| Q1 2022 | $1,463,000 | +168.4% | 55,604 | +214.6% | 0.10% | +31.5% |
| Q3 2021 | $545,000 | – | 17,676 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 14,040,000 | $313,513,000 | 35.43% |
| Krensavage Asset Management, LLC | 1,411,682 | $31,523,000 | 10.04% |
| Prosight Management, LP | 502,150 | $11,213,000 | 6.01% |
| Hardman Johnston Global Advisors LLC | 5,734,259 | $128,046,000 | 5.76% |
| 13D Management LLC | 415,055 | $9,268,000 | 4.85% |
| Ally Bridge Group (NY) LLC | 300,000 | $6,699,000 | 4.42% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 593,000 | $13,248,000 | 4.25% |
| GREAT POINT PARTNERS LLC | 507,500 | $11,332,000 | 2.73% |
| Tamarack Advisers, LP | 200,000 | $4,466,000 | 2.62% |
| Zebra Capital Management LLC | 22,134 | $494,000 | 1.88% |